EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Alzheimer's disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expression

Ali S Ropri, Tiffany G Lam, Vrinda Kalia, Heather M Buchanan, Anne Marie W Bartosch, Elliot H H Youth, Harrison Xiao, Sophie K Ross, Anu Jain, Jayanta K Chakrabarty, Min Suk Kang, Deborah Boyett und 8 weitere

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.14194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Ali S Ropri und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Amyloid beta-Peptides, Neuroglia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, Thompson Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Normal pressure hydrocephalus (NPH) patients undergoing cortical shunting frequently show early Alzheimer's disease (AD) pathology on cortical biopsy, which is predictive of progression to clinical AD. The objective of this study was to use samples from this cohort to identify cerebrospinal fluid (CSF) biomarkers for AD‐related central nervous system (CNS) pathophysiologic changes using tissue and fluids with early pathology, free of post mortem artifact. METHODS We analyzed Simoa, proteomic, and metabolomic CSF data from 81 patients with previously documented pathologic and transcriptomic changes. RESULTS AD pathology on biopsy correlates with CSF β‐amyloid‐42/40, neurofilament light chain (NfL), and phospho‐tau‐181(p‐tau181)/ β ‐amyloid‐42, while several gene expression modules correlate with NfL. Proteomic analysis highlights seven core proteins that correlate with pathology and gene expression changes on biopsy, and metabolomic analysis of CSF identifies disease‐relevant groups that correlate with biopsy data. DISCUSSION As additional biomarkers are added to AD diagnostic panels, our work provides insight into the CNS pathophysiology these markers are tracking. Highlights AD CSF biomarkers correlate with CNS pathology and transcriptomic changes. Seven proteins correlate with CNS pathology and gene expression changes. Inflammatory and neuronal gene expression changes correlate with YKL‐40 and NPTXR, respectively. CSF metabolomic analysis identifies pathways that correlate with biopsy data. Fatty acid metabolic pathways correlate with β‐amyloid pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiomarkersAmyloid beta-PeptidesNeurogliatau ProteinsHumansFemaleMaleAgedNeuronsNeurofilament ProteinsProteomicsHydrocephalus, Normal PressureGene ExpressionMiddle Aged

Stichwörter der Autor:innen

Alzheimer's diseaseCSFbiomarkersmetabolomicsproteomics

Substanzen

BiomarkersAmyloid beta-Peptidestau ProteinsNeurofilament Proteinsneurofilament protein L

Autor:innen und Institutionen

  • Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
  • Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, New York, USA.
  • Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, USA.
  • Quantitative Proteomics and Metabolomics Center, Department of Biological Sciences, Columbia University, New York, New York, USA.
  • Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA.
  • Department of Neurosurgery, Columbia University Irving Medical Center, New York, New York, USA.

ORCID-Profile: Andrew F Teich

Förderung

  • NIA NIH HHS
  • NIH HHS
  • Thompson Family Foundation
  • National Institutes of Health

Zitieren

APA

Ropri, A. S., Lam, T. G., Kalia, V., Buchanan, H. M., Bartosch, A. M. W., Youth, E. H. H., Xiao, H., Ross, S. K., Jain, A., Chakrabarty, J. K., Kang, M. S., Boyett, D., Spinazzi, E. F., Iodice, G., McGovern, R. A., Honig, L. S., Brown, L. M., Miller, G. W., McKhann, G. M., & Teich, A. F. (2024). Alzheimer's disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expression. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14194

Vancouver

Ropri AS, Lam TG, Kalia V, Buchanan HM, Bartosch AMW, Youth EHH, et al. Alzheimer's disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expression. Alzheimer's & Dementia. 2024. doi:10.1002/alz.14194

BibTeX
@article{Ropri2024,
  author = {Ropri, Ali S and Lam, Tiffany G and Kalia, Vrinda and Buchanan, Heather M and Bartosch, Anne Marie W and Youth, Elliot H H and Xiao, Harrison and Ross, Sophie K and Jain, Anu and Chakrabarty, Jayanta K and Kang, Min Suk and Boyett, Deborah and Spinazzi, Eleonora F and Iodice, Gail and McGovern, Robert A and Honig, Lawrence S and Brown, Lewis M and Miller, Gary W and McKhann, Guy M and Teich, Andrew F},
  title = {Alzheimer's disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expression},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.14194}
}
Kostenlos starten →